313 results on '"Dold, Markus"'
Search Results
2. The clinical perspective on late-onset depression in European real-world treatment settings
3. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
4. Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder
5. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
6. Die therapieresistente Depression (TRD) – Herausforderungen und praktisches Management
7. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
8. Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression
9. The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder : A Meta-Analysis of Randomized Controlled Trials
10. Melancholic features in major depression – a European multicenter study
11. The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression
12. The clinical perspective on late-onset depression in European real-world treatment settings
13. Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study
14. Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
15. Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials
16. Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
17. Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study
18. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study
19. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder – Findings from a European multicenter study
20. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
21. Dose Escalation of Antidepressants in Unipolar Depression : A Meta-Analysis of Double-Blind, Randomized Controlled Trials
22. Silexan for treatment of anxiety and depression in the context of COVID-19
23. Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
24. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study
25. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study
26. Implementation and testing of different control strategies on a steer-by-wire research platform
27. Age as a moderating factor of treatment resistance in depression
28. Age as a moderating factor of treatment resistance in depression
29. Dose escalation of antipsychotic drugs in schizophrenia: A meta-analysis of randomized controlled trials
30. Second-Generation Antipsychotic Drugs in Anorexia Nervosa : A Meta-Analysis of Randomized Controlled Trials
31. Psychotherapy’s Role for Treatment-Resistant Depression?
32. The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
33. Horten und Sammeln im Spektrum der Zwangsstörungen
34. Anxiety disorders in primary care
35. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials
36. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
37. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study
38. The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
39. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
40. Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
41. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report
42. Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
43. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study
44. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis
45. Implementation and testing of different control strategies on a steer-by-wire research platform
46. How to prevent and manage hyperammonemic encephalopathies in valproate therapy
47. The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
48. Increasing placebo response in antipsychotic trials: a clinical perspective
49. Sex‐related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
50. Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.